seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
  • Publication
  • Newsroom
  • Get in Touch
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
    • Publication
    • Newsroom
    • Get in Touch

     

    seek and you will find

    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
    • Publication
    • Newsroom
    • Get in Touch
    • …  
      • Home
      • Technology
      • Products 
        • Products Overview
        • SeekInCare
        • SeekInCure
        • SeekInClarity
        • OncoSeek
        • LeukoPrint
      • Publication
      • Newsroom
      • Get in Touch

      SeekIn Demonstrates the Power of Treatment Response Monitoring Test at the Association for Molecular Pathology (AMP) 2022 Annual Meeting & Expo

      · Press Releases

      SeekInClarity is a CE-IVD Mark, cost-effective, blood-based pan-cancer/pan-indication treatment response monitoring test that does not require cancer tissue analysis.

      SeekInClarity test could identify a subgroup of patients as responders, who have better survival regardless of disease subtypes and stages, after the first or second cycles of treatment.

      https://www.biospace.com/article/releases/seekin-demonstrates-the-power-of-treatment-response-monitoring-test-at-the-association-for-molecular-pathology-amp-2022-annual-meeting-and-expo/

       

      Previous
        SeekIn Presents New Data Supporting its Pan-cancer...
      Next
      SeekIn Receives CE-IVD Mark for Cancer Recurrence...
       Return to site
      All Posts
      ×

      Almost done…

      We just sent you an email. Please click the link in the email to confirm your subscription!

      OK